Cardlytics, Inc.
US ˙ NasdaqGM ˙ US14161W1053

SecurityCDLX / Cardlytics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership55,969 shares
Latest Disclosed Value $ 64,364
Barclays Plc reports 31,167.60% increase in ownership of CDLX / Cardlytics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 55,969 shares of Cardlytics, Inc. (US:CDLX) valued at $64,364 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 179 shares of Cardlytics, Inc.. This represents a change in shares of 31,167.60% during the quarter. The current value of the position is $34,147 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F CARDLYTICS COM 14161W105 55,969 55,790 31,167.60 64 -65.41 0.0000
2026-03-31 2025-09-30 13F/A-3 CARDLYTICS COM 14161W105 179 -13,735 -98.71 0 -100.00 0.0000
2026-03-19 2025-09-30 13F/A-2 CARDLYTICS COM 14161W105 58,026 44,112 186 0.0000
2025-11-12 2025-09-30 13F CARDLYTICS COM 14161W105 179 -13,735 0 0.0000
2026-02-27 2025-06-30 13F/A-2 CARDLYTICS COM 14161W105 13,914 -39,520 -73.96 23 -77.32 0.0000
2025-08-14 2025-06-30 13F/A-1 CARDLYTICS COM 14161W105 13,914 -39,520 0 0.0000
2025-08-13 2025-06-30 13F CARDLYTICS COM 14161W105 13,914 -39,520 0 0.0000
2026-03-17 2025-03-31 13F/A-1 CARDLYTICS COM 14161W105 53,434 -19,821 -27.06 97 -64.21 0.0000
2025-05-15 2025-03-31 13F CARDLYTICS COM 14161W105 53,434 -19,821 0 0.0000
2026-03-19 2024-12-31 13F/A-1 CARDLYTICS COM 14161W105 73,255 15,229 26.25 272 46.49 0.0001
2025-02-13 2024-12-31 13F CARDLYTICS COM 14161W105 73,255 15,229 0 0.0001
2026-03-31 2024-09-30 13F/A-2 CARDLYTICS COM 14161W105 58,026 40,112 223.91 186 25.85 0.0000
2024-11-19 2024-09-30 13F/A-1 CARDLYTICS COM 14161W105 58,026 40,112 0 0.0000
2024-11-15 2024-09-30 13F CARDLYTICS COM 14161W105 58,026 40,112 0 0.0000
2026-03-23 2024-06-30 13F/A-1 CARDLYTICS COM 14161W105 17,914 -14,178 -44.18 147 -68.39 0.0000
2024-08-14 2024-06-30 13F CARDLYTICS COM 14161W105 17,914 -14,178 0 0.0000
2026-03-24 2024-03-31 13F/A-1 CARDLYTICS COM 14161W105 32,092 -23,100 -41.85 465 -8.46 0.0002
2024-05-15 2024-03-31 13F CARDLYTICS COM 14161W105 32,092 -23,100 0 0.0002
2026-03-25 2023-12-31 13F/A-1 CARDLYTICS COM 14161W105 55,192 -230,917 -80.71 508 -89.24 0.0002
2024-02-15 2023-12-31 13F CARDLYTICS COM 14161W105 55,192 -230,917 1 0.0002
2026-03-26 2023-09-30 13F/A-1 CARDLYTICS COM 14161W105 286,109 146,713 105.25 4,721 436.36 0.0029
2023-11-07 2023-09-30 13F CARDLYTICS COM 14161W105 286,109 146,713 5 0.0029
2026-03-30 2023-06-30 13F/A-2 CARDLYTICS COM 14161W105 139,396 115,637 486.71 881 1,000.00 0.0006
2023-09-20 2023-06-30 13F/A-1 CARDLYTICS COM 14161W105 139,396 115,637 1 0.0006
2023-08-03 2023-06-30 13F CARDLYTICS COM 14161W105 139,396 115,637 1 0.0006
2026-03-30 2023-03-31 13F/A-1 CARDLYTICS COM 14161W105 23,759 6,227 35.52 81 -20.79 0.0000
2023-05-04 2023-03-31 13F CARDLYTICS COM 14161W105 23,759 6,227 0 0.0000
2026-03-30 2022-12-31 13F/A-1 CARDLYTICS COM 14161W105 17,532 -14,568 -45.38 101 -66.56 0.0000
2023-02-13 2022-12-31 13F CARDLYTICS COM 14161W105 17,532 -14,568 0 0.0000
2022-11-03 2022-09-30 13F CARDLYTICS COM 14161W105 32,100 1,790 5.91 302 -55.33 0.0003
2022-08-12 2022-06-30 13F CARDLYTICS COM 14161W105 30,310 -23,057 -43.20 676 -76.95 0.0004
2022-05-16 2022-03-31 13F CARDLYTICS COM 14161W105 53,367 -34,835 -39.49 2,933 -49.68 0.0023
2022-02-23 2021-12-31 13F/A-1 CARDLYTICS COM 14161W105 88,202 24,776 39.06 5,829 9.49 0.0022
2022-02-14 2021-12-31 13F CARDLYTICS COM 14161W105 88,202 24,776 5,829 0.0007
2021-11-09 2021-09-30 13F CARDLYTICS COM 14161W105 63,426 15,060 31.14 5,324 -13.28 0.0024
2021-08-13 2021-06-30 13F CARDLYTICS COM 14161W105 48,366 6,116 14.48 6,139 32.45 0.0029
2021-05-13 2021-03-31 13F CARDLYTICS COM 14161W105 42,250 10,094 31.39 4,635 0.96 0.0025
2021-02-11 2020-12-31 13F CARDLYTICS COM 14161W105 32,156 -3,488 -9.79 4,591 82.47 0.0024
2020-11-12 2020-09-30 13F CARDLYTICS COM 14161W105 35,644 2,978 9.12 2,516 10.01 0.0015
2020-08-12 2020-06-30 13F CARDLYTICS COM 14161W105 32,666 88 0.27 2,287 100.79 0.0018
2020-05-13 2020-03-31 13F CARDLYTICS COM 14161W105 32,578 -8,056 -19.83 1,139 -55.40 0.0009
2020-02-10 2019-12-31 13F CARDLYTICS COM 14161W105 40,634 16,350 67.33 2,554 213.76 0.0014
2019-11-15 2019-09-30 13F/A-1 CARDLYTICS COM 14161W105 24,284 15,518 177.02 814 257.02 0.0005
2019-11-14 2019-09-30 13F CARDLYTICS COM 14161W105 24,284 15,518 814 188.1977
2019-08-14 2019-06-30 13F CARDLYTICS COM 14161W105 8,766 -3,021 -25.63 228 16.92 0.0001
2019-05-15 2019-03-31 13F CARDLYTICS COM 14161W105 11,787 11,787 195 0.0001
2019-02-14 2018-12-31 13F CARDLYTICS COM 14161W105 0 -2,229 -100.00 0 -100.00
2018-11-14 2018-09-30 13F CARDLYTICS COM 14161W105 2,229 1,182 112.89 56 143.48 0.0000
2018-08-14 2018-06-30 13F CARDLYTICS COM 14161W105 1,047 -10,887 -91.23 23 -86.86 0.0000
2018-05-15 2018-03-31 13F CARDLYTICS COM 14161W105 11,934 11,934 175 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.